A case of coronary rupture and pseudoaneurysm formation after fracture of implanted paclitaxel-eluting stents

  • Yasuyuki Kawai
  • Michihiko Kitayama
  • Hironobu Akao
  • Atsushi Motoyama
  • Taketsugu Tsuchiya
  • Kouji Kajinami
Case Report


A 48-year-old man who had undergone implantation of two paclitaxel-eluting stents (PESs) at the right coronary artery was admitted to our hospital with progressive dyspnea. In the coronary care unit, he developed cardiogenic shock due to cardiac tamponade treated by pericardiocentesis. A coronary angiogram showed a large pseudoaneurysm at the site of the previously implanted stents, suggesting coronary rupture due to implanted stent fracture. The pseudoaneurysm was completely sealed by polytetrafluoroethylene-covered stent implantation. Although this case is very rare, coronary rupture by stent fracture should be considered when cardiac tamponade occurs after drug-eluting stent implantation, especially PES.


Coronary rupture Pseudoaneurysm Percutaneous coronary intervention Paclitaxel-eluting stent Polytetrafluoroethylene-covered stent 



We acknowledge the contributions of Dr. R Saito and Dr. S Takano for their assistance with the procedure, and Mr. T Nakagawa and Mr. S Takama for their technical support in the catheterization laboratory.

Conflict of interest

None declared.


  1. 1.
    Chen D, Chang R, Ho AT, Frivold G, Foster G. Spontaneous resolution of coronary artery pseudoaneurysm consequent to percutaneous intervention with paclitaxel-eluting stent. Tex Heart Inst J. 2008;35:189–92.PubMedPubMedCentralGoogle Scholar
  2. 2.
    Hagau AMT, Dudea SM, Hagau R, Hagau N. Large coronary pseudoaneurysm with pulmonary artery fistula, 6 months after left main trunk stenting with paclitaxel-eluting stent. Med Ultrason. 2013;15:59–62.CrossRefPubMedGoogle Scholar
  3. 3.
    Hori D, Noguchi K, Nomura Y, Tanaka H. Enlarged coronary artery pseudoaneurysm after drug-eluting stent implantation. Asian Cardiovasc Thorac Ann. 2012;21:608–11.CrossRefGoogle Scholar
  4. 4.
    Furtado AD, Bhat SPS, Peer SM, Chikkatur R. Infected pseudoaneurysm involving a drug-eluting stent. Interact CardioVasc Thorac Surg. 2011;12:636–8.CrossRefPubMedGoogle Scholar
  5. 5.
    Kapoor A, Batra A, Kumar S, Pandey S, Agarwal SK, Sinha N. Coronary pseudoaneurysm in a non-polymer drug-eluting stent: a rare entity. Asian Cardiovasc Thorac Ann. 2011;19:407–10.CrossRefPubMedGoogle Scholar
  6. 6.
    Choi JH, Song BG, Song YB, Hahn JY, Choi SH, Kim WS, et al. Catastrophic coronary stent fracture and coronary perforation presenting as cardiogenic shock: a rare but fatal complication of stenting. Circ Cardiovasc Imaging. 2008;1:e7–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Le MQ, Narins CR. Mycotic pseudoaneurysm of the left circumflex coronary artery. Catheter Cardiovasc Interv. 2007;69:508–12.CrossRefPubMedGoogle Scholar
  8. 8.
    Marcu CB, Balf DV, Donohue TJ. Post-infectious pseudoaneurysm after coronary angioplasty using drug eluting stents. Heart Lung Circ. 2005;14:85–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Candemir B, Altin T, Eda S, Durdu S, Ozcan OU, Akyurek O. Coronary rupture and pseudoaneurysm formation after extravascular migration of a paclitaxel eluting stent implanted in the left circumflex coronary artery. Herz. 2013;38:219–22.CrossRefPubMedGoogle Scholar
  10. 10.
    Sandhu PS, Kaul U. Coronary stent fracture resulting in pseudoaneurysm. Indian Heart J. 2012;64:622–3.CrossRefPubMedPubMedCentralGoogle Scholar
  11. 11.
    Maroo A, Rasmussen PA, Masaryk TJ, Ellis SG, Lincoff AM, Kapadia S. Stent-assisted detachable coil embolization of pseudoaneurysms in the coronary circulation. Catheter Cardiovasc Interv. 2006;68:409–15.CrossRefPubMedGoogle Scholar
  12. 12.
    Bajaj S, Parikh R, Hamdan A, Bikkina M. Covered-stent treatment of coronary aneurysm after drug-eluting stent placement. Tex Heart Inst J. 2010;37:449–54.PubMedPubMedCentralGoogle Scholar
  13. 13.
    Doi H, Maehara A, Mintz GS, Tsujita K, Kubo T, Castellanos C, et al. Classification and potential mechanisms of intervascular ultrasound patterns of stent fracture. Am J Cardiol. 2009;103:818–23.CrossRefPubMedGoogle Scholar
  14. 14.
    Wessely R, Schomig A, Kastrati A. Sirolimus and paclitaxel on polymer-based drug-eluting stents. Similar but different. J Am Coll Cardiol. 2006;47:708–14.CrossRefPubMedGoogle Scholar
  15. 15.
    Levin AD, Vokmirovic N, Hwang CW, Edelman ER. Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxel. Proc Natl Acad Sci USA. 2004;101:9463–7.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Hietala EM, Salminen US, Ståhls A, Välimaa T, Maasilta P, Törmälä P, et al. Biodegradation of the copolymeric polylactide stent. J Vasc Res. 2001;38:361–9.CrossRefPubMedGoogle Scholar
  17. 17.
    Virmani R, Liistro F, Stankovic G, Mario CD, Montorfano M, Farb A, et al. A mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans. Circulation. 2002;106:2649–51.CrossRefPubMedGoogle Scholar
  18. 18.
    Goodwin SC, Yoon HC, Chen G, Abdel-Sayed P, Costantino MM, Bonilla SM, et al. Intense inflammatory reaction to heparin polymer-coated intravascular Palmaz stents in porcine arteries compared to uncoated Palmaz stents. Cardiovasc Intervent Radiol. 2003;26:158–67.CrossRefPubMedGoogle Scholar
  19. 19.
    Vaghetti M, Palmieri C. A coronary pseudoaneurysm within a restenosis stent treated by implantation of a pericardium-covered stent and drug-eluting balloon. J Invasive Cardiol. 2013;25:E93–5.PubMedGoogle Scholar

Copyright information

© Japanese Association of Cardiovascular Intervention and Therapeutics 2015

Authors and Affiliations

  • Yasuyuki Kawai
    • 1
  • Michihiko Kitayama
    • 2
  • Hironobu Akao
    • 1
  • Atsushi Motoyama
    • 1
  • Taketsugu Tsuchiya
    • 2
  • Kouji Kajinami
    • 1
  1. 1.Department of CardiologyKanazawa Medical UniversityIshikawaJapan
  2. 2.Division of Cardiovascular InterventionKanazawa Medical UniversityIshikawaJapan

Personalised recommendations